Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-25-102166
Filing Date
2025-10-24
Accepted
2025-10-24 16:06:01
Documents
27
Period of Report
2025-10-24

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0261240-01.htm   iXBRL PRE 14A 1113408
2 GRAPHIC tbarchart_001.jpg GRAPHIC 583510
3 GRAPHIC tbarchart_002.jpg GRAPHIC 542985
4 GRAPHIC timage_001.jpg GRAPHIC 21254
5 GRAPHIC timage_002.jpg GRAPHIC 12342
6 GRAPHIC timage_003.jpg GRAPHIC 21198
7 GRAPHIC timage_004.jpg GRAPHIC 1611929
8 GRAPHIC timage_005.jpg GRAPHIC 1491350
9 GRAPHIC tmarlan_sig.jpg GRAPHIC 14305
10 GRAPHIC tproxy_001a.jpg GRAPHIC 1561272
11 GRAPHIC tproxy_002.jpg GRAPHIC 1041535
12 GRAPHIC ttherapeuticsmd_logo.jpg GRAPHIC 38886
  Complete submission text file 0001213900-25-102166.txt   19070725

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE txmd-20251103.xsd EX-101.SCH 14075
14 XBRL DEFINITION FILE txmd-20251103_def.xml EX-101.DEF 9603
15 XBRL LABEL FILE txmd-20251103_lab.xml EX-101.LAB 45182
16 XBRL PRESENTATION FILE txmd-20251103_pre.xml EX-101.PRE 14279
29 EXTRACTED XBRL INSTANCE DOCUMENT ea0261240-01_htm.xml XML 499533
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-00100 | Film No.: 251416213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)